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Objective. To evaluate the expression of CD64 and CD163 on neutrophils and monocytes in SIRS with/without sepsis and to
compare the diagnostic accuracy of CD64 andCD163 molecules expression determined as (1) mean ﬂuorescence intensities (MFI)
of CD64 and CD163; and (2) the ratio (index) of linearized MFI to the ﬂuorescence signal of standardized beads. Patients and
methods. Fifty-six critically ill neonates and children with systemic inﬂammatory response syndrome (SIRS) and suspected sepsis,
classiﬁedintotwogroups:SIRSwithsepsis(n = 29)andSIRSwithoutsepsis(n = 27).Results.CD64andCD163MFImeasuredon
neutrophils and monocytes were elevated in patients with SIRS with sepsis. Diagnostic accuracy of indexes was equal to diagnostic
accuracy of MFI for CD64 on neutrophils (0.833 versus 0.854 for day 0 and 0.975 versus 0.983 for day 1) and monocytes (0.811
versus 0.865 for day 0 and 0.825 versus 0.858 for day 1), and CD163 on neutrophils (0.595 versus 0.655 for day 0 and 0.677
versus 0.750 for day 1), but not for CD163 on monocytes. Conclusion. CD64 MFI, CD163 MFI, CD64 indexes for neutrophils and
monocytes, and CD163 index for neutrophils can all be used for discrimination of SIRS and sepsis in critically ill neonates and
children. CD64 index for neutrophils, however, is superior to all other markers.
Copyright © 2008 Mojca Groselj-Grenc et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
CD64 is a high-aﬃnity and restricted isotype-speciﬁcity
FcγRI receptor expressed on macrophages, monocytes, neu-
trophils, and eosinophils [1, 2]. There are several reports
regarding its potential utility for the diagnostic assessment of
sepsis or infection in adults [3–8] and neonates [9–12], but
only a few in children [13, 14]. In an adult study, a higher
intensity of CD64 expression has been found on neutrophils
from patients with systemic inﬂammatory response syn-
drome (SIRS) and sepsis than on neutrophils from patients
with SIRS only [3]. High CD64 expression on monocytes
accompanying high CD64 expression on neutrophils has
been reported in some adult studies as well [5, 15, 16].
CD163 is a monocyte/macrophage-associated antigen
which has recently been identiﬁed as a haemoglobin scav-
enger receptor [17]. Apart from clearance of haemoglobin, it
has also anti-inﬂammatory properties and an immunoregu-
latory role [18]. It has been found that CD163 expression on
a monocyte surface is inversely related to the concentration
of its soluble form (sCD163) in randomly selected patients
[19]. During human experimental endotoxinemia, a rapid
rise in plasma sCD163 has been observed together with
reduced surface CD163 expression on isolated monocytes
following lipopolysaccharide (LPS) administration, suggest-
ing that LPS induces shedding of CD163 from the surface of
isolated monocytes. Twenty-four hours after LPS adminis-
tration in humans, CD163 surface expression is consistently
increased over the baseline expression [20]. Soluble CD163
has been found to be elevated in sepsis in adults [21–23],
whereas surface expression of membrane CD163 (mCD163)
in sepsis has not yet been evaluated.
The ﬁrst aim of the study was to evaluate the expression
of CD64 and CD163 on neutrophils and monocytes in2 Mediators of Inﬂammation
Table 1: Characteristics of the study population.
SIRS with sepsis SIRS without sepsis
Number 29 27
Male/female 12/17 16/11
Median PRISM III (range) 11 (4–26) 12 (2–23)
Number of deaths 0 3 (11%)
Number of mechanically ventilated patients 27 (93%) 27 (100%)
Number of patients with severe sepsis 16 (55%) /
Number of patients with septic shock 12 (41%) /
Number of patients with inotropic drugs 12 (41%) 9 (33%)
Number of neonates <28 days 15 22
Number of newborns (0–7 days) 13 20
Median age (range); days 1 (0–18) 0 (0–13)
Median gestational age (range); weeks 38.2 (32.4–41.0) 37.9 (32.4–41.4)
Median birth weight (range); g 2945 (1400–3850) 3025 (1350–3920)
Number of children >28 days 14 5
Median age (range); months 9.3 (1.9–33.0) 4.2 (1.4–65.9)
Number of gram-positive sepsis 11 /
Number of gram-negative sepsis 10 /
Number of culture-negative sepsis 8 (28%) /
Number of positive blood cultures 8 (28%) /
Number of positive tracheal aspirates 13 (44%) /
critically ill neonates and children with SIRS and sepsis and
to ﬁnd out whether it can discriminate between infectious
and noninfectious SIRS. SIRS is most commonly caused by
infection, but other conditions such as low-cardiac output
syndrome, respiratory distress, and haemorrhage can trigger
it in neonates and children. It has been found that as many as
82% of children admitted to a paediatric intensive care unit
have two or more signs of SIRS [24].
The second aim of the study was to compare the
diagnostic accuracy of CD64 mean ﬂuorescence intensity
(MFI), CD163 MFI, CD64 index of linearised MFI to
standardised beads, and CD163 index of linearised MFI to
standardizedbeadsmeasuredonneutrophilsandmonocytes.
With recently available software for data analysis and index
calculation, sources of technical errors and subjectivity,
which are present in manual methods, are reduced and
a comparison of results between diﬀerent laboratories is
possible [25].
2. PATIENTS AND METHODS
2.1. Patientsandsetting
This prospective observational study was conducted in the
level III multidisciplinary neonatal and paediatric intensive
care unit between January 2006 and September 2006. Fifty-
six consecutive patients with SIRS and clinically suspected
infections were eligible for enrolment. SIRS was deﬁned
according to the international pediatric sepsis consensus
conference deﬁnitions [26]. Clinically suspected infection
was deﬁned as an explicit statement by the physician in the
records, indicating the suspicion of an infection, combined
with the initiation of diagnostic workup to rule out infection
and the prescription of empirical antibiotic therapy. Patients
were not included if they had received antibiotic therapy
for more than 24 hours prior to admission, if they had
undergone surgery in the previous week, or if they had a
proven viral infection. The diagnosis of sepsis was conﬁrmed
by positive blood cultures or tracheal aspirates when chest
radiographs showed signs of pneumonia. There were no
other cultures (urine, cerebrospinal, or a puncture of
normally sterile body ﬂuid) positive in our patients. The
diagnosis of clinical sepsis was established in patients with
negative cultures, but with a strong suspicion of sepsis,
who received a full course of antibiotic therapy. The group
without sepsis included patients with a suspected infection
in whom the subsequent clinical course, laboratory data,
and microbiological tests excluded infection, and in whom
antibiotic therapy was discontinued after a few days. Patients
were classiﬁed into two groups: SIRS with sepsis and SIRS
without sepsis. The classiﬁcation was carried out by the
attending physician unaware of the results of ﬂow cytometry.
We analyzed data separately for two age groups: neonates
aged less than 28 days, and children older than 28 days,
and for gram-positive and gram-negative sepsis. Patients’
characteristicsaresummarizedinTable 1.Pathogensisolated
from blood cultures were Staphylococcus epidermidis (n = 3),
Streptococcus agalactiae (n = 2), Neisseria meningitidis (n =
1), Streptococcus pneumoniae (n = 1) and Streptococcus mitis
(n = 1), while pathogens isolated from tracheal aspirates
were Haemophilus inﬂuenzae (n = 5), Streptococcus pneumo-
niae (n = 3), Moraxella catarrhalis (n = 2), Escherichia coliMojca Groselj-Grenc et al. 3
Table 2: Median CD64 and CD163 MFI and indexes (i) for neutrophils and monocytes with 95% conﬁdence interval (CI) in critically ill
neonates and children at the time of suspected sepsis (day 0) and 24 hours later (day 1).
Day 0 Day 1
SIRS with sepsis SIRS P SIRS with sepsis SIRS P
Neutrophils
CD64fMFI 83 (66–108) 44 (36–56) .0000∗ 100 (75–162) 47 (32–54) .0000∗
CD64i 2.65 (2.02–4.03) 1.3 (1.06–1.78) .0000∗ 3.36 (2.27–4.68) 1.47 (1.07–1.78) .0000∗
CD163MFI 65 (50–85) 47 (44–64) .0463∗ 80.5 (57–115) 50.5 (40.2–84.8) .0056∗
CD163i 456 (423–548) 447 (381–491) .2250 527 (486–621) 462 (426–528) .0495∗
Monocytes
CD64MFI 251 (231–294) 168 (149–212) .0000∗ 307 (257–354) 195 (159–243) .0001∗
CD64i 9.36 (7.94–11.2) 6.69 (5.6–7.28) .0001∗ 11 (8.39–13.4) 7.41 (6.43–8.22) .0003∗
CD163MFI 2350 (1674–3942) 1451 (1234–1637) .0063∗ 3281 (2369–4093) 2483 (1927–2937) .0439∗
CD163i 20080 (9330–27352) 9460 (7708–14893) .0836 21136 (13636–32551) 20142 (15926–25366) .9598
∗statistically signiﬁcant diﬀerences, Unpaired Mann-Whitney test.
(n = 1), Staphylococcus aureus (n = 1), and Pseudomonas
aeruginosa (n = 1).
The two groups were similar regarding gender (χ2 test,
P = 0.288), Pediatric Risk of Mortality Score (PRISM) III
score (ANOVA, P = 0.835), age (ANOVA, P = 0.212 and
P = 0.278 for neonates and children, resp.), gestational age
(ANOVA, P = 0.839) and birth weight (ANOVA, P = 0.720).
The study was approved by the National Medical Ethics
Committee of the Ministry of Health, Republic of Slovenia,
and written consent was obtained from parents before blood
sampling.
2.2. Samplecollectionandﬂowcytometry
Blood samples (0.5ml) were obtained at the time of sus-
pected sepsis (day 0) and 24 hours later (day 1) together
with samples for routine laboratory tests. Whole blood
EDTA-anticoagulatedsampleswereimmediatelytransported
to the ﬂow cytometry laboratory during working hours or
stored refrigerated (4◦C) during the night or at weekends
(up to 36 hours). Expressions of CD64 and CD163 on
neutrophils, monocytes, and lymphocytes were measured
by quantitative ﬂow cytometry with a FACSCalibur ﬂow
cytometer (Becton Dickinson, NY, USA) using the Leuko64
assay (Trillium Diagnostics, LLC, Me, USA). The assay is for
research use only and is composed of three antibodies with
speciﬁcities to CD64 (clones 22 and 32.2, both ﬂuorescein
isothiocyanate (FITC) conjugated) and to CD163 (clone
Mac2-148,phycoeritrin(PE)conjugated),andaﬂuorescence
bead suspension with three ﬂuorescence signals (green
ﬂuorescence due to FITC, orange ﬂuorescence similar to PE,
and red ﬂuorescence of starﬁre red) for unique identiﬁcation
of beads, and used for instrument calibration and standard-
ization of leukocyte CD64 and CD163 expression in human
blood. The sample preparation and ﬂow cytometer setup
were based on the manufacturer instructions. Brieﬂy, 50 μL
of whole blood, or diluted whole blood to adjust leukocyte
concentration to less than 25 × 109/L, was incubated for 15
minutes in the dark at room temperature with a mixture
of murine monoclonal antibodies followed by red cell lysis
with an ammonium-chloride-based red cell lysis solution
(Trillium Lyse). Fluorescence beads were then added and
ﬂow cytometer analysis was performed on a minimum of
50000 leukocytes. Data analysis for ﬂuorescence intensity
was performed by CellQuest software (Becton Dickinson,
Calif, USA) (Table 2). MFI was measured as a linearized
value of log scale on lymphocytes (red, negative control,
measuring CD64 expression), monocytes (green, positive
control, measuring CD64, and CD163 expression), neu-
trophils (blue, measuring CD64 expression), and beads
(aqua blue, measuring FITC, and PE expression) (Figure 1).
Index calculation was performed by Leuko64 QuantiCalc
software (Trillium Diagnostics, Me, USA). Index measure-
ments were derived by the ratio of linearized MFI of the cell
population to the FITC signal from the beads. An internal
negative control of the assay was provided by the automated
measurement of the lymphocyte CD64 index, which had to
be less than 1.0, and an internal positive control of the assay
was provided by automated measurement of the monocyte
CD64 index, which had to be more than 3.0. Flow cytometry
was performed up to 36 hours after blood sampling. Before
the beginning of the study the inﬂuence of delayed sample
analysis was done and no signiﬁcant diﬀerence in levels
of CD64 and CD163 expression was detected in the ﬁrst
36 hours after blood sampling. Isotype-control antibodies
were routinely used in each experiment to detect nonspeciﬁc
staining; however the calculation of CD64 and CD163 MFI
was done without substracting isotype-control MFI in order
to accurately compare the ratio (index) of linearized MFI to
MFI alone.
2.3. Statisticalanalysis
Data were presented as the median and 95% conﬁdence
interval for the median. Comparison between groups was
made using the unpaired Mann-Whitney test and analysis of4 Mediators of Inﬂammation
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Figure 1: Gating of neutrophils, monocytes, and lymphocytes in FSC/SSC representative FACS diagrams. CD64 and CD163 histograms
(colored) versus CD64 isotype controls (lined) are presented for granulocytes (red), lymphocytes (green), and monocytes (blue).Mojca Groselj-Grenc et al. 5
variance (ANOVA). Proportions of patients were compared
bytheχ2 test.Receiver-operatingcharacteristic(ROC)curves
were drawn to deﬁne the optimal sensitivity, speciﬁcity,
cutoﬀ value, and diagnostic accuracy, determined by the
area under the ROC curve (AUC) of the studied surface
antigens [27, 28]. The cutoﬀ values at which the greatest sum
of sensitivity and speciﬁcity was obtained were determined
by the statistical program. Hanely and McNeil’s compar-
ison of diagnostic accuracies was performed. The CD64
score point (combination of two variables: CD64 MFI on
neutrophils and monocytes or index CD64 for neutrophils
and monocytes) was calculated for CD64 MFI and CD64
index, separately as described elsewhere [29]. When CD64
ﬂuorescence intensity or CD64 index on both neutrophils
and monocytes was under the cutoﬀ level, the score point
of 0 was assigned. The score point of 1 was assigned when
the marker on one type of cells was under and marker on
the other type of cells was over the cutoﬀ level and the
score point of 2 was assigned when markers on both types
o fc e l l sw e r eo v e rt h ec u t o ﬀ levels. The ROC curve analysis
of CD64 score point was then performed. The diﬀerences
were considered to be statistically signiﬁcant at the level of
P<. 05.ThestatisticalanalysiswasperformedusingMedcalc
for Windows, version 5.0 (MedCalc Software, Mariakerke,
Belgium) and Statistical Package for the Social Sciences for
Windows, version 12.0 (SPSS Inc., Chicago, ILL, USA).
3. RESULTS
CD64 MFIs, CD163 MFIs, and CD64 indexes for both
neutrophils and monocytes were signiﬁcantly higher in
patients with SIRS with sepsis compared with patients
with noninfectious SIRS, while CD163 indexes showed
statistical diﬀerences only on neutrophils on day 0 (Table 2).
Statistically signiﬁcant increase (P<. 05) from day 0 to
day 1 was found only for CD163 MFI for neutrophils in
children with SIRS with sepsis and for CD163 MFI and
index for monocytes in children with noninfectious SIRS.
Medians of CD64 index for neutrophils were higher in
children with sepsis than in neonates with sepsis, although
diﬀerences were not signiﬁcant (P>. 05) at the time of
suspected sepsis and 24 hours later (Figure 2). We did not
ﬁnd any statistically signiﬁcant diﬀerences for CD64 and
CD163 indexes, and CD64 and CD163 MFIs for neutrophils
or monocytes, between gram-positive and gram-negative
sepsis (P>. 05 for all comparisons, data not shown).
Optimum diagnostic cutoﬀ levels, AUCs, sensitivity and
speciﬁcity of CD64 and CD163 indexes, CD64 and CD163
MFIsforneutrophilsandmonocytes,andCD64scorepoints,
for SIRS with sepsis at the time of suspected sepsis and
24 hours later are presented in Table 3. Setting sensitivity
at more than 95% in ROC analysis of CD64 index for
neutrophils displayed cutoﬀ point 1.15 on day 0 (sensitivity
96.6% and speciﬁcity 40.7%) and 1.71 (sensitivity 100%
and speciﬁcity 75.0%) on day 1. There were no signiﬁcant
diﬀerences between diagnostic accuracies of MFI and the
correspondingindexforeitherparameter,CD64andCD163,
onneutrophilsandmonocytesatthetimeofsuspectedsepsis
and 24 hours later (P>. 05 for all comparisons), except for
diagnosticaccuracyofCD163MFIformonocytes,whichwas
signiﬁcantly higher at 24 hours than diagnostic accuracy of
the CD163 index for monocytes (P = .003). The ROC curves
of diﬀerent indexes at the time of suspected sepsis and 24
hours later are presented in Figure 3. Diagnostic accuracies
of CD64 indexes for neutrophils and monocytes at the time
of suspected sepsis were both signiﬁcantly higher compared
with diagnostic accuracies of CD163 index for neutrophils
(P = .000 and P = .023, resp.) and of CD163 index for
monocytes (P = .028 and P = .050, resp.). Diagnostic
accuracy of CD64 index for neutrophils at 24 hours was
signiﬁcantly higher compared with diagnostic accuracies of
CD64 index for monocytes (P = .009), CD163 index for
neutrophils (P = .000), and CD163 index for monocytes
(P = .000). The combinations of two variables: CD64 MFI
for neutrophils with CD64 MFI for monocytes or CD64
indexforneutrophilswithCD64indexformonocytes(CD64
score point) insigniﬁcantly increased diagnostic accuracy of
CD64 MFI (P = .559) or CD64 index (P = .534) for
neutrophils on day 0, while there was an insigniﬁcant fall in
diagnostic accuracy (P = .494 and P = .128, resp.) on day 1
(Table 3).
4. DISCUSSION
To our knowledge, this is the ﬁrst study which has evaluated
expression of leukocyte antigens CD64 and CD163 in
critically ill neonates and children with SIRS with sepsis.
In this study, we have shown that expression of CD64 and
CD163 on neutrophils and monocytes is elevated in patients
with sepsis compared with patients with noninfectious SIRS.
We have also shown that diagnostic accuracy of computer-
calculated indexes for CD64 on neutrophils and monocytes
and CD163 on neutrophils based on the ratio (index) of
linearized MFI to the ﬂuorescence signal of standardised
beads, is equal to the diagnostic accuracy of manually
determined MFI, if proceeded by the same ﬂow cytometer.
Our results therefore suggest that the cost-eﬀectiveness of
tests, based on multiple antibodies (CD64 and CD163) and
standardized beads should be reevaluated.
CD64 is expressed at low concentration on the surface of
nonactivated neutrophils [30]. CD64 surface upregulation is
induced by granulocyte colony-stimulating factor (G-CSF)
and interferon-γ (INF-γ) within 4–6 hours of stimulation
[25]. Our study conﬁrmed the results from studies of
the adult population that the level of CD64 expression
is signiﬁcantly higher in patients with SIRS with sepsis
compared with patients with noninfectious SIRS [3]. In
our study, the expression of CD64 on neutrophils was
signiﬁcantlyhigherincriticallyillneonatesandchildrenwith
SIRS with sepsis compared with those with noninfectious
SIRS. So far, CD64 expression on leukocytes has been
studied mostly in the neonatal population. These studies
showed that CD64 expression on neutrophils is upregulated
in early-neonatal infection [9, 10], late-neonatal infection
[11, 12], and in preterm neonates with infection [11, 13].
Some authors have even suggested that, because of its high
sensitivity,measurementofneutrophilCD64expressionmay
allow clinicians to discontinue antimicrobial treatment if6 Mediators of Inﬂammation
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Figure 2: CD64 indexes for neutrophils at the time of suspected sepsis (day 0), and 24 hours later (day 1), for separate groups of neonates
and children. Data are presented as box plots (median value and interquartile range). Outliers and extreme cases of index CD64 are not
shown.
Table 3: Optimum diagnostic cutoﬀ level, diagnostic accuracy with 95% conﬁdence interval (CI) determined by the area under the ROC
curve (AUC), sensitivity, and speciﬁcity for given cutoﬀ levels of CD64 and CD163 MFI and indexes (i) for neutrophils and monocytes and
CD64 score points for sepsis prediction in critically ill neonates and children at the time of suspected sepsis (day 0) and 24 hours later (day
1).
Cutoﬀ level AUC (95% CI) Sensitivity (%) Speciﬁcity (%)
Day 0 1 0 1 0 1 0 1
CD64MFI for
neutrophils 72 65 0.854 (0.734–0.934) 0.983 (0.885–0.995) 65.5 95.5 92.6 95.0
CD64i for
neutrophils 2.45 2.19 0.833 (0.709–0.919) 0.975 (0.872–0.996) 65.5 86.4 88.9 100
CD64MFI for
monocytes 228 266 0.865 (0.747–0.941) 0.858 (0.715–0.946) 72.4 72.7 88.9 95.0
CD64i for
monocytes 8.70 9.47 0.811 (0.684–0.903) 0.825 (0.677–0.924) 65.5 63.6 96.3 95.0
CD163MFI for
neutrophils 47 55 0.655 (0.516–0.777) 0.750 (0.592–0.870) 75.9 86.4 51.9 60.0
CD163i for
neutrophils 391 482 0.595 (0.455–0.724) 0.677 (0.515–0.813) 86.2 77.3 37.0 65.0
CD163MFI for
monocytes 1641 3033 0.713 (0.576–0.826) 0.682 (0.520–0.817) 75.9 63.6 74.1 85.0
CD163i for
monocytes 19257 34282 0.635 (0.495–0.759) 0.500 (0.338–0.654) 51.7 27.3 88.9 95.0
CD64MFI
score point >0( 1a n d2 ) >0 (1 and 2) 0.879 (0.764–0.951) 0.961 (0.851–0.995) 86.2 100.0 85.2 90.0
CD64i
score point >0( 1a n d2 ) >0 (1 and 2) 0.864 (0.746–0.941) 0.914 (0.785–0.977) 82.8 90.9 88.9 80.0Mojca Groselj-Grenc et al. 7
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Figure 3: Receiver-operating characteristic (ROC) curves of CD64 and CD163 indexes (i) for neutrophils and monocytes for critically ill
neonates and children with SIRS with sepsis and SIRS without sepsis at the time of suspected sepsis (day 0) and 24 hours later (day 1).
negative within 24 hours of suspected infection, without
waiting for the deﬁnitive microbiological results [9]. The
results of our research are in accordance with the results
of this other study [9] only to some extent. The AUCs in
both studies were similar, but in the other study [9], higher
sensitivity was achieved, probably because the cutoﬀ values
were determined in advance to enable better sensitivity with
the aim to identify all infected cases. Due to the diﬀerent
method of ﬂow cytometry used for the measurement of
CD64 expression in the other study [9], the cutoﬀ values
cannot be compared. In our study, the cutoﬀ values were
determined by the statistical program to obtain the greatest
sumofsensitivityandspeciﬁcityforcomparisonsofdiﬀerent
markers. In order to increase the sensitivity we determined
the cutoﬀ values at which the sensitivity was 96.6% and
100%, respectively, on day 0 and 1. The speciﬁcity was then
slightly lower on day 1 than that in the previously mentioned
study [9]. Three cases of sepsis caused by coagulase-negative
staphylococci could have lowered the sensitivity of CD64
expression on neutrophils in our study, whereas in the other
study [9] there were no such cases. In children, there are only
tworeportsof14infantsandchildren,and8children,respec-
tively, hospitalized because of diﬀerent bacterial infections
(mostly pneumonias and pyelonephritides) in whom CD64
expression on neutrophils was signiﬁcantly higher compared
with noninfected controls [13, 14]. So far, CD64 expression
has not been studied in septic critically ill children. In
adult patients, higher expression of CD64 on neutrophils
was found in gram-negative sepsis compared with gram-
positive sepsis [15]. In the recent study in neonates [31], as
in our study, this diﬀerence was not conﬁrmed. The cause
for this diﬀerence between adults and neonates could be a
less expressed neutrophil response to infection with gram-
negative bacteria in neonates. Indeed, we found lower CD64
index in neonates with sepsis than in children, although the
diﬀerence was not statistically signiﬁcant. A novel marker
of infection, the CD64 score point, which incorporates the
quantitativeanalysisofCD64expressiononbothneutrophils
and monocytes has recently been introduced as a marker in
adultswhichcoulddistinguishbetweeninfectionandhealthy
states [29]. In our study, the CD64 score point was able
to discriminate between SIRS with sepsis and noninfectious
SIRS as well, although its diagnostic accuracy was not higher
than that of CD64 expression on neutrophils themselves.
To our knowledge, CD64 expression on monocytes in
neonatesandchildrenhasnotpreviouslybeenstudied.There
are some reports of elevated CD64 expression on monocytes
in adult patients with sepsis [5, 15, 16]. In our study, the
results of CD64 on monocytes and neutrophils were similar
at the time of suspected sepsis, but 24 hours later the
diagnostic accuracy of CD64 on monocytes was signiﬁcantly
lower than on neutrophils. This data could indicate that
activation in monocytes is faster or more rapidly completed
than in neutrophils [32].
The increased expression of CD163 is a part of the
maturation of a monocyte to a phagocytic macrophage [18].
The expression of CD163 is upregulated by interleukin-
6 and glucocorticoids together with interleukin-10, and8 Mediators of Inﬂammation
downregulated by LPS and interferon-γ [18]. Although the
absolute value of median expression of CD163 was much
lower on neutrophils than on monocytes in our patients
with sepsis, the expression of CD163 on both types of
cells could diﬀerentiate between patients with SIRS with
sepsis and noninfectious SIRS in our study. As dynamics of
ﬂuorescence intensity for CD64 and CD163 on neutrophils
was diagnostically very signiﬁcant, it is highly unlikely that
a nonspeciﬁc staining would have been the cause. Also,
the representative FACS diagrams made possible quite a
sharp distinction between cell populations without causing
serious problems in cell gating. Our results therefore indicate
that, like monocytes, neutrophils are able to some extent to
express CD163.
Membrane CD163 expression has not yet been clin-
ically evaluated. Only one author found increased bone
marrow inﬁltration with CD163-positive macrophages in
postmortemanalysisofsamplesfrompatientswhodiedfrom
severe sepsis or septic shock compared with controls [33].
In contrast, high concentrations of soluble CD163 (sCD163)
have been described in adult septic patients in several studies
[3, 21]. It has been shown experimentally with cultured
monocytes that CD163 can be shed from the cell membrane
after LPS stimulus [20], cross-linking of the Fc receptor
for immunoglobulin G [34] or oxidative stress [35]. The
shedding of CD163 from monocyte membrane correlates
with decreased expression of membrane CD163 on cultured
monocytes [20, 34]. The decreased expression of membrane
CD163 is probably partly due to shedding of CD163 [20]
and partly due to decreased CD163 mRNA synthesis [34,
36]. In healthy adult volunteers, CD163 surface expression
was increased again 24 hours after LPS stimulation [20].
The precise time point of increased expression is not yet
exactly known, but it was estimated to be 0–24 hours after
LPS stimulation in adult volunteers [20]o re v e nl a t e ri n
cultured monocytes [34]. It was shown that stimulation
with LPS induced short-term suppression of CD163 mRNA
expression in cultured monocytes, while long-term cultures
of monocytes treated with LPS showed intereleukin-10
dependent recovery of surface CD163 expression [34]. In
our clinical study, we did not observe the transitional fall of
membrane CD163 expression on monocytes. The expression
of CD163 on both monocytes and neutrophils was higher in
septic patients than in patients with noninfectious SIRS both
at the time of suspected sepsis and 24 hours later. The reason
may be that clinical signs are observed with signiﬁcant delay
after endotoxinemia.
Most clinical studies in the past have used manually
determined ﬂuorescence intensity to describe CD64 expres-
sion on neutrophils. This method, however, is subject to day-
to-dayoperationalandinstrumentalﬂuctuationsandcannot
be used for comparison between diﬀerent laboratories. The
newly developed method for computer-calculated indexes
usescalibrationbeadswhichserveasaninternalﬂuorescence
intensity standard and, together with fully automated soft-
ware for index calculation, which removes the subjectivity
in data analysis by the end users, provide a novel approach
in minimizing lot-to-lot variation, and in removing the
subjectivity due to diﬀerent range of experience and skills
of operators [25]. In our study, comparison of manually
determined ﬂuorescence intensity and computer-calculated
index revealed that diagnostic accuracy of both parameters
was equal for CD64 on neutrophils and monocytes and
CD163 on neutrophils, but not for CD163 on monocytes.
Our explanation is that automated index calculation was
originally developed for evaluation of CD64 index on
neutrophils in diﬀerent clinical conditions [25] and the
method is probably not universally transmittable to evaluate
all other antigens on diﬀerent cell types for diagnostic
purposes. The calculation of CD64 index for neutrophils,
which achieved the highest diagnostic accuracy in our study,
was optimal and we suggest that this parameter should be
used in future evaluations. We found no studies, except for a
poster presentation at Sepsis 2007 in Paris [37], which have
used index calculation for evaluation of CD64 expression on
neutrophils.
Some limitations of this study merit consideration.
Firstly, the deﬁnition of clinical sepsis with culture-negative
patients, particularly critically ill neonates, is still a matter
of discussion. Secondly, the number of patients is relatively
small. A greater number of neonates and children is needed
for a more precise evaluation of diagnostic accuracies
of selected infection markers (CD64 and CD163 index
for monocytes and neutrophils) and for comparison with
routinely used infection markers in the future. The blood
samples were processed within 36 hours in our study.
For clinical use, the method should be available every
day, particularly because some authors suggest processing
of blood specimens for analysis of cell surface markers
immediately after obtaining them to avoid cell apoptosis
[30]. However, other authors claim that measurements for
neutrophil CD64 assay are stable for up to 30 hours at room
temperature and up to 72 hours refrigerated [25]. As we
already mentioned, no signiﬁcant diﬀerences in levels of
CD64 and CD163 expressions were obtained in the ﬁrst 36
hours after blood sampling in our study.
5. CONCLUSION
The data from the present study show that CD64 and
CD163 expressions on neutrophils and monocytes are
elevated in critically ill neonates and children with SIRS
with sepsis. Diagnostic accuracies of computer-calculated
indexes for CD64 on neutrophils and monocytes and CD163
on neutrophils based on the ratio (index) of linearised
MFI to the ﬂuorescence signal of standardized beads are
equal to diagnostic accuracy of manually determined MFI, if
processedbythesameﬂowcytometer.Therefore,CD64MFI,
CD163 MFI, CD64 indexes for neutrophils and monocytes
and CD163 index for neutrophils can all be used for
discriminationofSIRSandsepsisincriticallyillneonatesand
children. CD64 index for neutrophils, however, is superior to
all other markers.
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